Tyra Biosciences, Inc.

Importer · United States

Biotechnology

About Tyra Biosciences, Inc.

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines targeting opportunities in fibroblast growth factor receptor (FGFR) biology. The company's in-house precision medicine platform, SNÅP, enables rapid and precise refinement of structural drug design through iterative molecular snapshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines targeting opportunities in fibroblast growth factor receptor (FGFR) biology. The company's in-house precision medicine platform, SNÅP, enables rapid and precise refinement of structural drug design through iterative molecular snapshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Company LinkedIn URL: Not Available